Generated: April 26, 2017
|Title:||HIV protease inhibitors|
|Abstract:||Compounds useful as intermediates in the preparation of HIV protease inhibitors. These compounds have the following general formula: ##STR1##|
|Inventor(s):||Dressman; Bruce A. (Indianapolis, IN), Fritz; James E. (Greenwoode, IN), Hammond; Marlys (Pasadena, CA), Hornback; William J. (Indianapolis, IN), Kaldor; Stephen W. (Indianapolis, IN), Kalish; Vincent J. (San Diego, CA), Munroe; John E. (Indianapolis, IN), Reich; Siegfried Heinz (San Diego, CA), Tatlock; John H. (Poway, CA), Shepherd; Timothy A. (Indianapolis, IN), Rodriguez; Michael J. (Indianapolis, IN)|
|Assignee:||Agouron Pharmaceuticals, Inc. (San Diego, CA)|
|Filing Date:||Jun 21, 2001|
|Claims:||1. A compound of the formula: ##STR134## |
or a pharmaceutically acceptable salt or solvate thereof.